ZIM Laboratories Limited (BOM:541400)

Market Cap	3.47B
Revenue (ttm)	3.66B
Net Income (ttm)	65.86M
Shares Out	48.74M
EPS (ttm)	1.35
PE Ratio	52.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,251
Average Volume	3,507
Open	74.95
Previous Close	76.10
Day's Range	70.11 - 75.98
52-Week Range	64.10 - 126.95
Beta	0.44
RSI	46.82
Earnings Date	Feb 11, 2026

About ZIM Laboratories

ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and ...

• Industry: Pharmaceutical Preparations
• Founded: 1984
• Employees: 577
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 541400

Financial Performance

In 2024, ZIM Laboratories's revenue was 3.79 billion, an increase of 3.16% compared to the previous year's 3.68 billion. Earnings were 121.65 million, a decrease of -29.46%.